利伐沙班治疗难治性肝素诱导的血小板减少症。
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.
作者信息
Casan Joshua Misha Lewis, Grigoriadis George, Chan Noel, Chunilal Sanjeev
机构信息
Department of Haematology, Monash Health, Clayton, Victoria, Australia.
出版信息
BMJ Case Rep. 2016 Aug 12;2016:bcr2016216110. doi: 10.1136/bcr-2016-216110.
Abstract
Following orthopaedic surgery, a 56-year-old woman developed heparin-induced thrombocytopenia (HIT), complicated by extensive proximal deep vein thrombosis. The patient did not respond to multiple conventional therapies; however, a prompt treatment response occurred after starting rivaroxaban at standard dosing. This case represents the first documentation of efficacy for rivaroxaban in the setting of treatment refractory HIT and strengthens the limited existing evidence for this agent in HIT.
摘要
一名56岁女性在接受骨科手术后发生肝素诱导的血小板减少症（HIT），并伴有广泛的近端深静脉血栓形成。该患者对多种传统疗法均无反应；然而，在开始使用标准剂量的利伐沙班后迅速出现治疗反应。该病例是利伐沙班在治疗难治性HIT中的疗效的首次记录，并加强了该药物在HIT中现有有限的证据。
相似文献
1
Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.利伐沙班治疗难治性肝素诱导的血小板减少症。
BMJ Case Rep. 2016 Aug 12;2016:bcr2016216110. doi: 10.1136/bcr-2016-216110.
2
[Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].[利伐沙班治疗肝素诱导的血小板减少症。病例报告]
Rev Med Chil. 2017 Sep;145(9):1213-1217. doi: 10.4067/s0034-98872017000901213.
3
Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.利伐沙班成功治疗肝素诱导的血小板减少症伴深静脉血栓形成和肺栓塞：临床病例报告及当前经验回顾
J Cardiovasc Pharmacol. 2016 Nov;68(5):391-394. doi: 10.1097/FJC.0000000000000421.
4
Rivaroxaban for heparin-induced thrombocytopenia: adding to the evidence.利伐沙班用于肝素诱导的血小板减少症：补充证据
Ann Hematol. 2017 Mar;96(3):525-527. doi: 10.1007/s00277-016-2871-z. Epub 2016 Nov 7.
5
Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.利伐沙班作为肝素诱导的血小板减少症的替代药物。
J Clin Pharmacol. 2020 Oct;60(10):1362-1366. doi: 10.1002/jcph.1635. Epub 2020 Jun 10.
6
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?利伐沙班能否作为治疗肺血栓栓塞症合并肝素诱导的血小板减少症患者的首选药物？
Anatol J Cardiol. 2017 Jul;18(1):77-79. doi: 10.14744/AnatolJCardiol.2017.7805.
7
Design of the rivaroxaban for heparin-induced thrombocytopenia study.利伐沙班用于肝素诱导的血小板减少症研究的设计。
J Thromb Thrombolysis. 2014 Nov;38(4):485-92. doi: 10.1007/s11239-014-1064-7.
8
Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.利伐沙班治疗疑似或确诊肝素诱导血小板减少症研究。
J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.
9
Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.利伐沙班和阿哌沙班用于治疗疑似或确诊的肝素诱导的血小板减少症。
J Clin Pharm Ther. 2022 Jan;47(1):112-118. doi: 10.1111/jcpt.13537. Epub 2021 Oct 26.
10
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.利伐沙班治疗心脏手术后肝素诱导的血小板减少症：一例报告
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e19-20. doi: 10.1016/j.jtcvs.2015.04.054. Epub 2015 May 8.
引用本文的文献
1
Autoimmune Heparin-Induced Thrombocytopenia.自身免疫性肝素诱导的血小板减少症
J Clin Med. 2023 Nov 3;12(21):6921. doi: 10.3390/jcm12216921.
2
Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience.利伐沙班治疗肝素诱导的血小板减少症：一例病例报告及当前经验综述。
Case Rep Hematol. 2020 Sep 3;2020:8885256. doi: 10.1155/2020/8885256. eCollection 2020.
3
Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay.自身免疫性肝素诱导的血小板减少症：治疗障碍与住院时间挑战
Am J Case Rep. 2019 Mar 9;20:310-313. doi: 10.12659/AJCR.914575.
本文引用的文献
1
Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.利伐沙班治疗疑似或确诊肝素诱导血小板减少症研究。
J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.
2
Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.利伐沙班治疗心脏手术后肝素诱导的血小板减少症：一例报告
J Thorac Cardiovasc Surg. 2015 Aug;150(2):e19-20. doi: 10.1016/j.jtcvs.2015.04.054. Epub 2015 May 8.
3
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.利伐沙班用于肝素诱导的血小板减少症的治疗。
J Thromb Thrombolysis. 2015 Oct;40(3):392-4. doi: 10.1007/s11239-015-1208-4.
4
Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia.利伐沙班用于肝素诱导的血小板减少症相关的动脉血栓形成。
Blood Coagul Fibrinolysis. 2015 Mar;26(2):205-6. doi: 10.1097/MBC.0000000000000205.
5
First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.利伐沙班用于治疗肝素诱导的血小板减少症的初步经验。
Thromb Res. 2015 Jan;135(1):205-7. doi: 10.1016/j.thromres.2014.06.005. Epub 2014 Jun 14.
6
Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.肝素诱导的血小板减少症的治疗和预防：抗血栓治疗与血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e495S-e530S. doi: 10.1378/chest.11-2303.
7
Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.利伐沙班——一种口服的直接Xa因子抑制剂——在治疗肝素诱导的血小板减少症患者方面具有潜力。
Br J Haematol. 2008 Oct;143(1):92-9. doi: 10.1111/j.1365-2141.2008.07300.x. Epub 2008 Jul 30.
8
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.与肝素结合的血小板第4因子是肝素诱导的血小板减少症中产生的抗体的靶标。
Thromb Haemost. 1992 Jul 6;68(1):95-6.
Zotero 插件